Volume 16, Issue 3 (2023)
Review Articles
Efficacy and Safety of Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma: A Systematic Review of Clinical Trials
Muhammad Ashar Ali
PARP Inhibitors for Treatment of BRCA1/2-Mutated Metastatic Breast Cancer- A Systematic Review and Meta-analysis
Ranju Kunwor, Daniel P. Silver, and Maysa Abu-Khalaf
Strategic priorities for hematopoietic stem cell transplantation in the EMRO region
Syed Osman Ahmed, Riad El Fakih, Alaa Elhaddad, Amir Ali Hamidieh, Abdulghani Altbakhi, Qamar-Un-Nisa Chaudhry, Ali Bazarbachi, Salman Adil, Murtadha Al-khabori, Tarek Ben Othman, Javid Gaziev, Mohamad Khalaf, Salem Alshammeri, Sultan Alotaibi, Mohammed Alshahrani, Mohamed Amine Bekadja, Ahmad Ibrahim, Adel Mohammed Al-Wahadneh, Muna Altarshi, Ahmad Alsaeed, Abdellah Madani, Miguel Abboud, Husam Abujazar, Mohamad Bakr, Ibraheem Abosoudah, Jean El Cheikh, Ahlam Almasari, Feras Alfraih, Helen Baldomero, Hassan Elsolh, Dietger Niederwieser, Naeem Chaudhri, and Mahmoud Aljurf
Acquired amegakaryocytic thrombocytopenic purpura: a review of therapeutic options
Syed Ather Hussain, Aneeqa Zafar, Hafsa Faisal, and Mohammad Ammad Ud Din
Research Articles
Geographic and Demographic Disparities in Colorectal Cancer: A Population-Based Study Using National Cancer Database
Turab Mohammed, Rohit Gosain, Navpreet Rana, Riccardo Lemini, Katy Wang, Asna Agha, Arun Neupane, Emmanuel M Gabriel, Steven Nurkin, and Patrick Boland
The impact of beta-blocker use at the time of hematopoietic cell transplantation on the development of acute and chronic graftversus- host disease
Arjun Patel, Guru Subramanian Guru Murthy, Mehdi Hamadani, Aniko Szabo, and Jennifer M. Knight
Heparanase wildtype is associated with a reduced incidence of transplant-associated systemic vasculopathies
Raphaela Mueckenhausen, Ju¨rgen Fo¨ll, Katharina Kleinschmidt, Anja Tro¨ger, Muriel Malaise´, Daniel Wolff, Ernst Holler, Marie Matthes, Tilman Heise, Gunhild Sommer, and Selim Corbacioglu
Outcomes of patients diagnosed with chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation: Results from a tertiary care center
Swe Mar Linn, Ram Vasudevan Nampoothiri, Carol Chen, Ivan Pasic, Zeyad Al-Shaibani, Wilson Lam, Arjun Datt Law, Fotios V. Michelis, Dennis D.H. Kim, Armin Gerbitz, Jeffrey Lipton, Rajat Kumar, Jonas Mattsson, and Auro Viswabandya
Oxidative stress and hepcidin expression in pediatric sickle cell anemia with iron overload
Eman A. Elbostany, Eman A. Elghoroury, Eman H. Thabet, Alaa A. Rashad, Enas A. Rasheed, Gamila S.M. El-Saeed, Dalia A. Abdelhalim, Safa N. Abdelfattah, Iman I. Salama, and Niveen Salama
Escalated dose donor lymphocyte infusion treatment in patients with primary immune deficiencies after HSCT with reducedintensity conditioning regimen
Tahani Ali, Maryam Behfar, Rashin Mohseni, Pourya Salajegheh, Maged Kheder, Faihaa Abou-Fakher, Zeynab Nikfetrat, Fahimeh Jafari, Parisa Naji, and Amir Ali Hamidieh
JAK2/STAT5 pathway mutation frequencies in South African BCR/ABL negative MPN patients
Shires K, Rust A, Harryparsad R, Coburn J, and Gopie R
Original Research Reports
Treatment Selection and Survival in Patients with Gray Zone Lymphoma; A Comprehensive Population-Based Analysis
Yazan Samhouri, Thejus T. Jayakrishnan, Lynna Alnimer, Veli Bakalov, Rodney E. Wegner, Cyrus Khan, Salman Fazal, and John Lister
Managing Sickle Cell Disease in Patients for Whom Blood Transfusion Is Not an Option
Bukky F. Tabiti, Sherri Ozawa, Arooj Mian, Megha Suri, Haley L. Yates, and Lewis L. Hsu
Effects of different types of allogeneic hematopoietic stem cell transplantation donors on Philadelphia chromosome-positive acute lymphoblastic leukemia during the tyrosine kinase inhibitor era: A systematic review and meta-analysis
Ben Ponvilawan, Weerapat Owattanapanich, Nipith Charoenngam, and Smith Kungwankiattichai
